EN
抗体药类似物
Research Grade Felvizumab
All
TD-VK421046_1.jpg
  • CatalogTD-VK421046
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsSB209763,HuRSV19VHFNS/VK,RSHZ19monoclonalantibody,SB209763,CAS:167747-20-8
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Felvizumab


Catalog No. TD-VK421046
Description Felvizumab [HuRSV19VHFNS/VK, RSHZ19, RSV monoclonal antibody, SB209763] is a humanised monoclonal antibody (IgG1) prepared by the humanization of an F protein-specific murine MAb. In in vitro studies, palivizumab, another humanized Mab specific for the F protein of RSV, was 4 to 5-fold more potent than felvizumab in neutralising RSV (Scott, 1999).
Species reactivity HRSV-A
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target F, Fusion glycoprotein F0, Fusion glycoprotein F2, p27, Intervening segment, Pep27, Peptide 27, Fusion glycoprotein F1
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P03420
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names SB209763,HuRSV19VHFNS/VK,RSHZ19monoclonalantibody,SB209763,CAS:167747-20-8
Background Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-VK421046_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Felvizumab.